Folgen
Jóhannes Reynisson
Jóhannes Reynisson
School of Pharmacy, Keele University, United Kingdom
Bestätigte E-Mail-Adresse bei keele.ac.uk - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Benchmarking the reliability of QikProp. Correlation between experimental and predicted values
L Ioakimidis, L Thoukydidis, A Mirza, S Naeem, J Reynisson
QSAR & Combinatorial Science 27 (4), 445-456, 2008
2952008
Sorption and biodegradation of organic micropollutants during river bank filtration: A laboratory column study
C Bertelkamp, J Reungoat, ER Cornelissen, N Singhal, J Reynisson, ...
Water research 52, 231-241, 2014
1882014
Target profiling of an antimetastatic RAPTA agent by chemical proteomics: relevance to the mode of action
MV Babak, SM Meier, KVM Huber, J Reynisson, AA Legin, MA Jakupec, ...
Chemical science 6 (4), 2449-2456, 2015
1662015
Characteristics of known drug space. Natural products, their derivatives and synthetic drugs
R Bade, HF Chan, J Reynisson
European journal of medicinal chemistry 45 (12), 5646-5652, 2010
1512010
New water-soluble copper (II) complexes with morpholine–thiosemicarbazone hybrids: Insights into the anticancer and antibacterial mode of action
K Ohui, E Afanasenko, F Bacher, RLX Ting, A Zafar, N Blanco-Cabra, ...
Journal of medicinal chemistry 62 (2), 512-530, 2018
1242018
Hit generation and exploration: imidazo [4, 5-b] pyridine derivatives as inhibitors of Aurora kinases
V Bavetsias, C Sun, N Bouloc, JÛ Reynisson, P Workman, ...
Bioorganic & medicinal chemistry letters 17 (23), 6567-6571, 2007
1212007
Synthesis and biological evaluation of novel tyrosyl-DNA phosphodiesterase 1 inhibitors with a benzopentathiepine moiety
A Zakharenko, T Khomenko, S Zhukova, O Koval, O Zakharova, ...
Bioorganic & Medicinal Chemistry 23 (9), 2044-2052, 2015
1192015
Anticancer Ruthenium(η6-p-cymene) Complexes of Nonsteroidal Anti-inflammatory Drug Derivatives
F Aman, M Hanif, WA Siddiqui, A Ashraf, LK Filak, J Reynisson, ...
Organometallics 33 (19), 5546-5553, 2014
1112014
Intercalation of trioxatriangulenium ion in DNA: binding, electron transfer, X-ray crystallography, and electronic structure
J Reynisson, GB Schuster, SB Howerton, LD Williams, RN Barnett, ...
Journal of the American Chemical Society 125 (8), 2072-2083, 2003
1092003
Imidazo[4,5-b]pyridine Derivatives As Inhibitors of Aurora Kinases: Lead Optimization Studies toward the Identification of an Orally Bioavailable Preclinical …
V Bavetsias, JM Large, C Sun, N Bouloc, M Kosmopoulou, M Matteucci, ...
Journal of medicinal chemistry 53 (14), 5213-5228, 2010
1072010
DFT calculations on the electrophilic reaction with water of the guanine and adenine radical cations. A model for the situation in DNA
J Reynisson, S Steenken
Physical Chemistry Chemical Physics 4 (3), 527-532, 2002
902002
Synthesis and cytotoxicity of thieno [2, 3-b] pyridine and furo [2, 3-b] pyridine derivatives
JM Hung, HJ Arabshahi, E Leung, J Reynisson, D Barker
European journal of medicinal chemistry 86, 420-437, 2014
882014
Half‐Sandwich Ruthenium (II) Biotin Conjugates as Biological Vectors to Cancer Cells
MV Babak, D Plażuk, SM Meier, HJ Arabshahi, J Reynisson, B Rychlik, ...
Chemistry–A European Journal 21 (13), 5110-5117, 2015
792015
Novel tyrosyl-DNA phosphodiesterase 1 inhibitors enhance the therapeutic impact of topoteсan on in vivo tumor models
AL Zakharenko, OA Luzina, DN Sokolov, VI Kaledin, VP Nikolin, ...
European Journal of Medicinal Chemistry 161, 581-593, 2019
782019
From Catalysis to Cancer: Toward Structure–Activity Relationships for Benzimidazol-2-ylidene-Derived N-Heterocyclic-Carbene Complexes as Anticancer Agents
NYS Lam, D Truong, H Burmeister, MV Babak, HU Holtkamp, ...
Inorganic chemistry 57 (22), 14427-14434, 2018
742018
The effect of PLC-γ2 inhibitors on the growth of human tumour cells
L Feng, I Reynisdóttir, J Reynisson
European journal of medicinal chemistry 54, 463-469, 2012
742012
New inhibitors of tyrosyl-DNA phosphodiesterase I (Tdp 1) combining 7-hydroxycoumarin and monoterpenoid moieties
T Khomenko, A Zakharenko, T Odarchenko, HJ Arabshahi, V Sannikova, ...
Bioorganic & medicinal chemistry 24 (21), 5573-5581, 2016
722016
Serendipity in anticancer drug discovery
E Hargrave-Thomas, B Yu, J Reynisson
World journal of clinical oncology 3 (1), 1, 2012
722012
Size estimation of chemical space: how big is it?
KLM Drew, H Baiman, P Khwaounjoo, B Yu, J Reynisson
Journal of Pharmacy and Pharmacology 64 (4), 490-495, 2012
702012
Investigation of the incidence of “undesirable” molecular moieties for high-throughput screening compound libraries in marketed drug compounds
P Axerio-Cilies, IP Castañeda, A Mirza, J Reynisson
European journal of medicinal chemistry 44 (3), 1128-1134, 2009
702009
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20